1 Min Read
April 25 (Reuters) - Jubilant Life Sciences Ltd
* Says Jubilant Life Sciences receives ANDA approval for olmesartan medoxomil tablets
* Says tablets used for treatment of hypertension Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.